Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Cash from Operations (2016 - 2025)

OptimizeRx (OPRX) has disclosed Cash from Operations for 16 consecutive years, with 7088000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 3479.8% to 7088000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 18715000.0 through Dec 2025, up 282.8% year-over-year, with the annual reading at 18715000.0 for FY2025, 282.8% up from the prior year.
  • Cash from Operations hit 7088000.0 in Q4 2025 for OptimizeRx, up from 3202000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 7088000.0 in Q4 2025 to a low of 6258000.0 in Q4 2023.
  • Historically, Cash from Operations has averaged 1387205.85 across 5 years, with a median of 1569375.0 in 2021.
  • Biggest five-year swings in Cash from Operations: tumbled 868.84% in 2023 and later skyrocketed 3479.8% in 2025.
  • Year by year, Cash from Operations stood at 1334543.0 in 2021, then soared by 310.07% to 2803484.0 in 2022, then crashed by 323.22% to 6258000.0 in 2023, then soared by 103.16% to 198000.0 in 2024, then surged by 3479.8% to 7088000.0 in 2025.
  • Business Quant data shows Cash from Operations for OPRX at 7088000.0 in Q4 2025, 3202000.0 in Q3 2025, and 4561000.0 in Q2 2025.